Clinical Trials Directory

Trials / Completed

CompletedNCT00932750

Study of Coffee Mannooligosaccharides for Weight Management

THE EFFECTS OF COFFEE MANNOOLIGOSACCHARIDES ON INDICES OF BODY WEIGHT, BODY COMPOSITION, AND SATIETY IN HUMANS

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
82 (actual)
Sponsor
Mondelēz International, Inc. · Industry
Sex
All
Age
20 Years – 65 Years
Healthy volunteers
Accepted

Summary

The goal of this study is to establish the role of coffee mannooligosaccharides (MOS), provided in a beverage format, on body weight regulation. Overweight and obese men and women will be randomized to one of 2 groups: placebo or MOS beverage. They will be required to consume 2 beverages/day for the duration of the 2 phases of the study. The MOS beverage will provide 2 g of MOS (total of 4 g/d). This dose level has been found to be well tolerated and safe. In the first phase, subjects will be counseled once monthly on a nutrition-related topic on an individual basis. They will be asked to maintain their regular eating and exercise habits for the duration of the 12 week period. An 8-week washout period will follow during which time they will not be required to consume the beverages. The second phase of the study will be a weight loss phase. For this phase, subjects will be re-randomized and may consume the alternate or the same beverage as the first phase, depending on the outcome of randomization. During this phase, they will undergo group counseling on a weekly basis. Counseling sessions will focus on weight loss and ways to achieve moderate weight loss of approximately 1-2 lbs/week. Measurements will be taken at the beginning and end of each phase. This study will allow us to determine whether MOS helps maintain body weight and prevent weight gain (first phase) and whether it helps to stimulate weight loss (second phase). The results will allow us to find ways in which overweight and obese individuals can incorporate beverages in their diets that will help promote weight loss.

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTCoffee mannooligosaccharide2 beverages daily providing either 4 g of coffee mannooligosaccharide or placebo.
DIETARY_SUPPLEMENTCoffee mannooligosaccharidesSubjects consume 2 beverages daily providing 4 g of coffee mannooligosaccharides or placebo

Timeline

Start date
2006-09-01
Primary completion
2007-11-01
Completion
2007-11-01
First posted
2009-07-03
Last updated
2012-08-22

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT00932750. Inclusion in this directory is not an endorsement.